{
    "2018-09-07": [
        [
            {
                "time": "2023-10-05",
                "original_text": "AstraZeneca's Asthma Drug Gets Breakthrough Therapy Status",
                "features": {
                    "keywords": [
                        "AstraZeneca",
                        "Asthma",
                        "Drug",
                        "Breakthrough",
                        "Therapy",
                        "Status"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "AstraZeneca's Asthma Drug Gets Breakthrough Therapy Status",
                "features": {
                    "keywords": [
                        "AstraZeneca",
                        "Asthma",
                        "Drug",
                        "Breakthrough",
                        "Therapy",
                        "Status"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Lilly, Teva, Pfizer & Others Await FDA Decisions in September",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Teva",
                        "Pfizer",
                        "FDA",
                        "Decisions",
                        "September"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}